HSBC Holdings’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

HSBC Holdings’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-707,037	Closed	-$7.23M	–	2862
2023 Q1	$7.23M	Buy	707,037 +6,050	+0.9%	+$61.4K	0.01%	980
2022 Q4	$7.07M	Buy	700,987 +42,801	+7%	+$426K	0.01%	1104
2022 Q3	$6.49M	Hold	658,186	–	–	0.01%	1077
2022 Q2	$6.41M	Buy	+658,186	New	+$6.43M	0.01%	1094

HSBC Holdings's ORIA Position: Q2 2023 in Review

HSBC Holdings sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 707,037 shares — an estimated $7.23M sold.

HSBC Holdings first reported a position in ORIA in Q2 2022 and held it in 4 quarters. The position peaked at $7.23M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

HSBC Holdings reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
HSBC Holdings sold 707,037 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $7.23M.
HSBC Holdings first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q2 2022 and held it in 4 quarters.
HSBC Holdings's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $7.23M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on HSBC Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.